According to new research announced today, the fragile X syndrome (FXS) market across the USA and Germany is projected to ...

A growth occurring in the next five years will be fuelled by the launch of two high-priced pipeline products providing ...

US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...

Scheduled Feeding improved sleep/wake rhythms in the Fmr1 KO mutants.

Strengths: (1) The manuscript addresses an important topic-investigating sleep deficits in an FXS mouse model and proposing a potential therapeutic strategy ... In the present study, the authors, ...

ucr.edu Background: Fragile X syndrome (FXS) is the most common single gene inherited form of mental retardation, with behaviours at the extreme of the autistic spectrum. Subjects with FXS and fragile ...

a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused autism ...